ProfileGDS4718 / 234021_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 57% 57% 44% 57% 57% 45% 46% 53% 60% 54% 50% 52% 50% 43% 46% 56% 52% 49% 47% 67% 54% 48% 59% 56% 51% 43% 53% 47% 64% 49% 44% 39% 62% 55% 47% 48% 52% 54% 46% 39% 54% 55% 44% 47% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.9498657
GSM549102patient 115, normal, homogenized [OPG study]5.9525757
GSM549104patient 119, normal, homogenized [OPG study]5.1803544
GSM549108patient 138, normal, homogenized [OPG study]5.9443257
GSM549119patient 077, normal, homogenized [OPG study]5.9265257
GSM549133patient 032, cancer, homogenized [OPG study]5.1799645
GSM549139patient 042, cancer, homogenized [OPG study]5.2830146
GSM549099patient 107, normal, homogenized [OPG study]5.7039753
GSM549109patient 139, normal, homogenized [OPG study]6.1669260
GSM549110patient 046, normal, homogenized [OPG study]5.7562954
GSM549114patient 063, normal, homogenized [OPG study]5.4698950
GSM549122patient 082, normal, homogenized [OPG study]5.6463152
GSM549134patient 033, cancer, homogenized [OPG study]5.5091450
GSM549136patient 036, cancer, homogenized [OPG study]5.1049243
GSM549140patient 044, cancer, homogenized [OPG study]5.2602546
GSM549111patient 047, normal, homogenized [OPG study]5.872956
GSM549113patient 057, normal, homogenized [OPG study]5.5999752
GSM549132patient 031, cancer, homogenized [OPG study]5.4291349
GSM549137patient 038, cancer, homogenized [OPG study]5.3505647
GSM549142patient 047, cancer, homogenized [OPG study]6.6810267
GSM549100patient 110, normal, homogenized [OPG study]5.7326954
GSM549107patient 135, normal, homogenized [OPG study]5.3788648
GSM549115patient 068, normal, homogenized [OPG study]6.024659
GSM549116patient 072, normal, homogenized [OPG study]5.8358256
GSM549120patient 078, normal, homogenized [OPG study]5.5452151
GSM549131patient 030, cancer, homogenized [OPG study]5.0739543
GSM549118patient 074, normal, homogenized [OPG study]5.6604853
GSM549129patient 027, cancer, homogenized [OPG study]5.3456147
GSM549123patient 088, normal, homogenized [OPG study]6.4086664
GSM549124patient 006, cancer, homogenized [OPG study]5.4668249
GSM549126patient 015, cancer, homogenized [OPG study]5.1883144
GSM549128patient 025, cancer, homogenized [OPG study]4.9246939
GSM549103patient 117, normal, homogenized [OPG study]6.2692162
GSM549117patient 073, normal, homogenized [OPG study]5.7635155
GSM549138patient 041, cancer, homogenized [OPG study]5.3131747
GSM549141patient 045, cancer, homogenized [OPG study]5.3470848
GSM549130patient 028, cancer, homogenized [OPG study]5.6169652
GSM549101patient 111, normal, homogenized [OPG study]5.7772554
GSM549105patient 128, normal, homogenized [OPG study]5.3078746
GSM549106patient 134, normal, homogenized [OPG study]4.8776739
GSM549112patient 048, normal, homogenized [OPG study]5.7384754
GSM549125patient 011, cancer, homogenized [OPG study]5.8066955
GSM549127patient 024, cancer, homogenized [OPG study]5.1871344
GSM549135patient 035, cancer, homogenized [OPG study]5.3220547